Toggle navigation
Home
Search
Services
Blog
Contact
About
Kappa Opiod-Coupled Second Messenger Systems
Konkoy, Christopher S.
Wake Forest University Health Sciences, Winston-Salem, NC, United States
Search 3 grants from Christopher Konkoy
Search grants from Wake Forest University Health Sciences
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Veterinarian Training in Laboratory Animal Medicine
Age Differences in Ethanol Effects: Tolerance and Reward
Analysis of Hsv Interactions with the Nervous System
Operation of A Human Serum Bank for Diagnostic Studies
WILSIM2, The Next Generation Landform Simulator
Recently added grants:
Peptidoglycan metabolism and fragment release
Survival of Neisseria gonorrhoeae after primary human neutrophil challenge
Diet driven evolution of epidemic ribotypes of Clostridium difficile
Bioactivities of pneumococcal cell wall in neuropathogenesis
Activation of semi-invariant and diverse NKT cells with an adjuvant combination
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31DA005400-02
Application #
3024371
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1991-12-01
Project End
Budget Start
1991-12-01
Budget End
1992-11-30
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Wake Forest University Health Sciences
Department
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Related projects
NIH 1992
F31 DA
Kappa Opiod-Coupled Second Messenger Systems
Konkoy, Christopher S. / Wake Forest University Health Sciences
NIH 1990
F31 DA
Kappa Opiod-Coupled Second Messenger Systems
Konkoy, Christopher S. / Wake Forest University Health Sciences
Comments
Be the first to comment on Christopher Konkoy's grant